{"id":"NCT03559257","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-31","primaryCompletion":"2019-06-19","completion":"2019-09-19","firstPosted":"2018-06-18","resultsPosted":"2020-07-08","lastUpdate":"2020-07-08"},"enrollment":463,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine"],"interventions":[{"type":"DRUG","name":"Galcanezumab","otherNames":["LY2951742"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Galcanezumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and efficacy of galcanezumab in people with treatment-resistant episodic or chronic migraine.","primaryOutcome":{"measure":"Overall Mean Change From Baseline in the Number of Monthly Migraine Headache Days","timeFrame":"Baseline, Month 1 through Month 3","effectByArm":[{"arm":"Placebo - Double-Blind Treatment Phase","deltaMin":-1.02,"sd":0.32},{"arm":"Galcanezumab 120mg - Double-Blind Treatment Phase","deltaMin":-4.14,"sd":0.32}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":69,"countries":["United States","Belgium","Canada","Czechia","France","Germany","Hungary","Japan","Netherlands","Puerto Rico","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["37016181","35930126","35076090","35041159","34592919","34542830","34264500","33892641","33765912","32949542"],"seeAlso":["https://www.lillytrialguide.com/en-US/studies/migraine/CGAW"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":230},"commonTop":["Nasopharyngitis","Injection site pain"]}}